中科微点-全球专利检索

  1. Login
  2. Sign Up
Invention Grant
US08664225B2 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of pain or residual symptoms in depression relating to sleep and cognition 有权
1- [2-（2,4-二甲基苯基硫烷基） - 苯基]哌嗪作为具有组合的5-羟色胺再摄取，5-HT3和5-HT1A活性的化合物，用于治疗与睡眠和认知相关的抑郁症中的疼痛或残留症状

  • Patent Title: 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of pain or residual symptoms in depression relating to sleep and cognition
  • Patent Title (中): 1- [2-（2,4-二甲基苯基硫烷基） - 苯基]哌嗪作为具有组合的5-羟色胺再摄取，5-HT3和5-HT1A活性的化合物，用于治疗与睡眠和认知相关的抑郁症中的疼痛或残留症状
  • Application No.: US12527911
    Application Date: 2008-03-14
  • Publication No.: US08664225B2
    Publication Date: 2014-03-04
  • Inventor: Nicholas Moore , Tine Bryan Stensbol
  • Applicant: Nicholas Moore , Tine Bryan Stensbol
  • Applicant Address: DK Valby-Copenhagen
  • Assignee: H. Lundbeck A/S
  • Current Assignee: H. Lundbeck A/S
  • Current Assignee Address: DK Valby-Copenhagen
  • Agency: Fish & Richardson P.C.
  • Priority: DK200700427 20070320; WOPCT/DK2007/050075 20070615
  • International Application: PCT/DK2008/050063 WO 20080314
  • International Announcement: WO2008/113359 WO 20080925
  • Main IPC: A61K31/4965
  • IPC: A61K31/4965
1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of pain or residual symptoms in depression relating to sleep and cognition
Abstract:
The use of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine in the treatment of pain and residual symptoms in depression is provided.
Abstract(Chinese):

提供1- [2-（2,4-二甲基苯基硫烷基）苯基]哌嗪用于治疗抑郁症中的疼痛和残留症状。

Public/Granted literature
Information query
Espacenet
Patent Agency Ranking
0/0